Cellbioengines

1 known investors

Cell BioEngines develops allogeneic off-the-shelf cell therapies derived from transgene-free stem cells for oncology and regenerative medicine applications. The company employs HLA-guided design and scalable manufacturing to create therapeutic cell-based products intended to function as drugs.

BiotechDeep TechMedical Devices